|
CDHR1 protein, human
|
C442481 |
|
|
eucalyptin
|
C442482 |
|
|
rad57 protein, S pombe
|
C442472 |
|
|
Product Labeling
|
D011356 |
[Use of written, printed, or graphic materials upon or accompanying a product or its container or wrapper. It includes purpose, effect, description, directions, hazards, warnings, and other relevant information.
] |
|
HMP-2 protein, C elegans
|
C442473 |
|
|
Product Line Management
|
D011357 |
[Management control systems for structuring health care delivery strategies around case types, as in DRGs, or specific clinical services.
] |
|
cora protein, Drosophila
|
C442474 |
|
|
Product Surveillance, Postmarketing
|
D011358 |
[Surveillance of drugs, devices, appliances, etc., for efficacy or adverse effects, after they have been released for general sale.
] |
|
Rasd2 protein, rat
|
C442475 |
|
|
Proestrus
|
D011359 |
[A phase of the ESTROUS CYCLE that precedes ESTRUS. During proestrus, the Graafian follicles undergo maturation.
] |
|
alpha-methylserine-O-phosphate monophenyl ester
|
C442477 |
|
|
N-phenyl-7-(hydroxyimino)cyclopropa(b)chromen-1a-carboxamide
|
C442478 |
|
|
DCHS1 protein, human
|
C442479 |
|
|
Proctocolitis
|
D011350 |
[Inflammation of the RECTUM and the distal portion of the COLON.
] |
|
Proctoscopy
|
D011351 |
[Endoscopic examination, therapy or surgery of the rectum.
] |
|
Procyclidine
|
D011352 |
[A muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism.
] |
|
Prodigiosin
|
D011353 |
[4-Methoxy-5-((5-methyl-4-pentyl-2H-pyrrol-2-ylidene)methyl)- 2,2'-bi-1H-pyrrole. A toxic, bright red tripyrrole pigment from Serratia marcescens and others. It has antibacterial, anticoccidial, antimalarial, and antifungal activities, but is used mainly as a biochemical tool.
] |
|
Prodigiozan
|
D011354 |
[A polysaccharide extracted from Serratia marcescens and other bacteria. It activates enzymatic activity of macrophages and stimulates phagocytic processes.
] |
|
Prodrugs
|
D011355 |
[A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
] |
|
Basic Reproduction Number
|
D050936 |
[The expected number of new cases of an infection caused by an infected individual, in a population consisting of susceptible contacts only.
] |
